FDA Issues Challenge To Medtech To Fight Opioid Crisis

Echoing President Trump's ongoing call to fight the opioid-abuse epidemic, the US agency is asking medtech companies to submit applications for new products to tackle the issue. Promising devices and diagnostic tools identified by the agency will get extra attention from FDA, but they won't have to submit an additional application for a Breakthrough Device designation.

PS1803_Opioid_746383330_1200.jpg

As the Trump administration continues to fight the opioid epidemic, US FDA has issued a challenge to medtech companies: Come up with solutions to the crisis and your product could be expedited to market through the agency's pre-market review process.

On May 30, FDA posted a challenge to medical device and diagnostics companies to present it with proposals for combatting...

More from Digital Technologies

More from Medtech Insight